ACID BASE DISORDERS IN CHRONIC LIVER DISEASE CHILD CLASS B AND C ITS CORELATION WITH IN-HOSPITAL MORTALITY
DOI:
https://doi.org/10.18623/rvd.v23.5951Palabras clave:
Chronic Liver Disease, Liver Cirrhosis, Acid-Base Imbalance, Metabolic Acidosis, Respiratory AlkalosisResumen
Background: Chronic liver disease (CLD) is a significant health burden in the world with high morbidity and mortality. The acid-base disorders (ABDs) are common in patients with a high liver disease and can lead to adverse clinical results. There is however limited information on their prevalence and prognostic effect in developing nations such as Pakistan. Objective: To identify the rate of acid-base disorders in chronic liver disease patients and to examine how these disorders relate to in-hospital mortality. Methodology: The study will be a descriptive study that will be carried out in the Department of General Medicine of the Fauji foundation hospital, Rawalpindi from October 2025 to January 2026. A sample size of 100 patients aged between 18 to 65 years with diagnosed CLD (Child-Pugh Class B and C) will be sampled through non-probability consecutive sampling. Arterial blood gas (ABG) will be used to determine acid-base status. The patients will be monitored within a period of 28 days to determine mortality. The analysis of data will be done under SPSS version 25. Results: It is believed that acid-base disorders especially the metabolic acidosis and respiratory alkalosis will be very common and greatly linked to high mortality. Summary: There is the possibility of early detection and treatment of acid-base disorders in CLD patients, which will positively affect the clinical outcomes and decrease mortality.
Citas
Achanti, A.; Szerlip, H. M. Acid-base disorders in the critically ill patient. Clinical Journal of the American Society of Nephrology, 2023, 18(1): 102–112.
Angeli, P.; Bernardi, M.; Villanueva, C. et al. Evolving concepts in decompensated cirrhosis. Journal of Hepatology, 2023, 78(2): 1–15.
Drolz, A.; Horvatits, T.; Roedl, K.; Rutter, K.; Brunner, R.; Zauner, C. et al. Acid-base status and its clinical implications in critically ill patients with cirrhosis, acute-on-chronic liver failure and without liver disease. Annals of Intensive Care, 2018, 8(1): 48.
Drolz, A.; Horvatits, T.; Roedl, K.; Rutter, K.; Brunner, R.; Zauner, C. et al. Acid-base status and its clinical implications in critically ill patients with cirrhosis, acute-on-chronic liver failure and without liver disease. Annals of Intensive Care, 2018, 8(1): 48.
Emmett, M. Review of clinical disorders causing metabolic acidosis. Advances in Chronic Kidney Disease, 2022, 29(4): 355–363.
Fadlallah, H.; El Masri, D.; Bahmad, H. F.; Abou-Kheir, W.; El Masri, J. Update on the complications and management of liver cirrhosis. Medical Sciences, 2025, 13(1): 1–5.
Gottfriedová, H.; Lánská, V.; Jabor, A.; Čáslavská, M.; Špičák, J.; Horáčková, M. et al. Spironolactone-furosemide combination therapy and acid-base disorders in liver cirrhosis patients. International Journal of Clinical Pharmacology and Therapeutics, 2020, 58(5): 261–267.
Gurnani, V.; Kumar, N.; Khan, S.; Nawaz, M. U.; Ahmed, H.; Naz, S. et al. Biochemical risk factors associated with hyperkalemia in cirrhotic patients. Cureus, 2021, 13(9): e18356.
Hernaez, R.; Ge, P. S.; Bajaj, J. S. et al. Prognostic models in cirrhosis: AASLD practice guidance. Hepatology, 2022, 76(1): 1–20.
Jiménez, J. V.; Carrillo-Pérez, D. L.; Rosado-Canto, R. et al. Electrolyte and acid-base disturbances in end-stage liver disease: A physiopathological approach. Digestive Diseases and Sciences, 2017, 62(8): 1855–1871.
Katopodis, P.; Pappas, E. M.; Katopodis, K. P. Acid-base abnormalities and liver dysfunction. Annals of Hepatology, 2022, 27(2): 100675.
Katopodis, P.; Pappas, E. M.; Katopodis, K. P. Acid-base abnormalities and liver dysfunction. Annals of Hepatology, 2022, 27(2): 100675.
Liu, Z. P.; Ouyang, G. Q.; Huang, G. Z.; Wei, J.; Dai, L.; He, S. Q.; Yuan, G. D. Global burden of cirrhosis and other chronic liver diseases due to nonalcoholic fatty liver disease, 1990–2019. World Journal of Hepatology, 2023, 15(11): 1210–1225.
Mannion, R.; Fitzpatrick, E. Systemic complications secondary to chronic liver disease. Indian Journal of Pediatrics, 2024, 91(3): 286–293.
Moreau, R.; Jalan, R.; Gines, P. et al. Acute-on-chronic liver failure is a distinct clinical syndrome. Journal of Hepatology, 2020, 73(6): e1–e9.
Scheiner, B.; Lindner, G.; Reiberger, T. et al. Acid-base disorders in liver disease. Journal of Hepatology, 2017, 67(5): 1062–1073.
Xu, E. J.; Zarm, A. M.; Lecker, S. H.; Hoenig, M. P. Acid-base disorders in cirrhosis. Advances in Chronic Kidney Disease, 2023, 30(4): 336–342.
Xu, J. H.; Yu, Y. Y.; Xu, X. Y. Management of chronic liver diseases and cirrhosis: current status and future directions. Chinese Medical Journal, 2020, 133(22): 2647–2649.
Descargas
Publicado
Cómo citar
Número
Sección
Licencia
I (we) submit this article which is original and unpublished, of my (our) own authorship, to the evaluation of the Veredas do Direito Journal, and agree that the related copyrights will become exclusive property of the Journal, being prohibited any partial or total copy in any other part or other printed or online communication vehicle dissociated from the Veredas do Direito Journal, without the necessary and prior authorization that should be requested in writing to Editor in Chief. I (we) also declare that there is no conflict of interest between the articles theme, the author (s) and enterprises, institutions or individuals.
I (we) recognize that the Veredas do Direito Journal is licensed under a CREATIVE COMMONS LICENSE.
Licença Creative Commons Attribution 3.0
